7.56
price down icon1.56%   -0.12
after-market After Hours: 7.56
loading

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast

The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $7.56. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 40.77 Neutral
STOCH(9,6) 46.55 Neutral
STOCHRSI(14) 52.57 Neutral
MACD(12,26) -0.2661 Sell
ADX(14) 18.02 Neutral
William %R -71.28 Neutral
CCI(14) -28.09 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
7.588
Sell
7.72
Sell
MA20
8.0665
Sell
7.9276
Sell
MA50
8.4089
Sell
8.4107
Sell
MA100
9.2707
Sell
9.1034
Sell
MA200
10.55
Sell
10.33
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, BBOT could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on BBOT, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 40.77 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 46.55 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 52.57 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 18.02 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -28.09 indicates that BBOT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast

$31.43
price up icon 0.74%
$90.89
price down icon 1.44%
$52.96
price down icon 1.38%
$63.96
price up icon 3.50%
ONC ONC
$270.15
price up icon 2.84%
$162.99
price up icon 3.31%
Cap:     |  Volume (24h):